The abstract is read at the publisher; the summary is JClub's.
A single low-dose intraperitoneal AAV9-GFP injection in neonatal mice transduces macula densa cells with ~85% of GFP+ cells being Nos1+ MD cells.
- Why it matters: Macula densa cells are central to kidney sensing and regulation but have lacked cell-specific, easy in vivo tools to study their functions.
- What they did: The study tested AAV9 delivery in neonatal mice (P2–3) and adults after low-salt diet, then used AAV9 to overexpress Ccn1 or knock down Pappa2 with shRNA.
- The result: MD-targeted gain- and loss-of-function models showed altered renin control, tubuloglomerular feedback glomerular hemodynamics, and tissue remodeling, supporting MD-specific gene therapy development.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.